McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Walgreens offers new tool for chronic care management

by McKesson Ventures | Jul 30, 2019 | Portfolio News

Walgreens is expanding the services available on its Walgreens Find Care digital platform to include chronic care management. The company is now offering connected devices and digital therapeutic solutions for asthma and COPD management from Propeller Health, and...

Inhaler Monitoring Cuts Hospitalization Usage, Study Finds

by McKesson Ventures | Jun 24, 2019 | Portfolio News

Patients with emphysema, also known as chronic obstructive pulmonary disease (COPD) whose inhalers were tracked by a monitoring device were less likely to need hospital admission, according to a new study by Propeller Health and the Cleveland Clinic. Electronic...

Propeller Health’s new deal with Orion Corporation extends its European reach

by McKesson Ventures | Feb 15, 2019 | Portfolio News

Wisconsin-based Propeller Health is partnering with Finnish pharmaceuticals and diagnostics company Orion Corporation to help European asthma and COPD sufferers. Starting in 2019, the companies will begin developing a custom-built Propeller sensor for Orion’s...

M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M

by McKesson Ventures | Dec 13, 2018 | Portfolio News

On December 3, ResMed announced that it was acquiring digital therapeutics manufacturer Propeller Health for $225 million. Part of ResMed’s goal in making this acquisition is to help establish itself as a leader in COPD management across all stages of the disease....

Asthma-related ER visits decline by more than half for patients using digitally connected inhalers

by McKesson Ventures | Dec 12, 2018 | Portfolio News

Dignity Health and Propeller Health recently released the results of a newly published, peer-reviewed study that shows asthma-related emergency room visits declined by more than 50 percent for people who used connected, digital medicine to manage their disease. The...
Page 2 of 4«1234»

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations

Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting

McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing

Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow